Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 450 of 6351
-
When waters break early, does acting fast beat waiting?
Disease control By invitation onlyThe goal of this randomized controlled trial is to compare planned early induction of labor with expectant management in women with term premature rupture of membranes (PROM) at 37-42 weeks of gestation. The main questions it aims to answer are: Does planned early induction of l…
Sponsor: Pakistan Institute of Medical Sciences • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New Imaging-Guided radiation aims to better control High-Risk prostate cancer
Disease control Not yet recruitingIn this study, prostate cancer patients whose cancer has not spread to the lymph nodes will receive radiation therapy targeted to the prostate and nearby tissues with or without whole pelvis radiation therapy. PSMA imaging will be used to visualize prostate cancer prior to starti…
Phase 2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New cream could ease painful skin condition lichen sclerosus
Disease control Recruiting nowThe main objective of the study is to evaluate the efficacy of twice daily applications of delgocitinib cream compared with cream vehicle in the treatment of adult participants with mild to severe lichen sclerosus (LS). The researchers are focusing on female participants because …
Phase 3 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New drug combo aims to beat hard-to-treat bone infections
Disease control Not yet recruitingA Multicenter, Prospective, Randomized Controlled Trial to Evaluate the Efficacy and Safety of Bisphosphonates Combined with Vancomycin in the Treatment of Refractory Osteomyelitis
Phase 3 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New drug cocktail targets brain tumors from lung and breast cancer
Disease control CancelledBrain metastasis represents one of the worst prognostic outcomes in advanced malignant tumors. Approximately 10% to 40% of patients with solid tumors develop brain metastases, a incidence rate significantly higher than that of primary malignant brain tumors. Over 80% of patients …
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could a blood spin help women with failed IVF get pregnant?
Disease control Not yet recruitingEndometrial receptivity is a key determinant of success in assisted reproductive technology (ART). A significant proportion of patients experience repeated implantation failure despite euploid embryos and adequate laboratory conditions. Thin endometrium, often defined as ultrasou…
Sponsor: Azienda Sanitaria Locale di Asti • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Can a blood thinner boost vision after retinal detachment surgery?
Disease control OngoingThis interventional prospective study was conducted in the Department of Ophthalmology at Lahore General Hospital, Lahore. The study included 60 male and female patients aged 18-65 years who had rhegmatogenous retinal detachment associated with grade C proliferative vitreoretinop…
Sponsor: Lahore General Hospital • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Could ozempic help men become fathers? new trial investigates
Disease control Not yet recruitingWhy is this study being done? Obesity can harm men's fertility by lowering sperm quality and hormone levels, making it harder to have children. Weight loss through diet and exercise helps, but it's often hard to stick with. New medicines called GLP-1 receptor agonists, like semag…
Phase 2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 26, 2026 17:30 UTC
-
New hope for advanced penile cancer: drug combo targets tough cases
Disease control Not yet recruitingPenile cancer is a rare malignant tumor of the male genitourinary system, with 95% being squamous cell carcinoma. Due to social factors, delayed diagnosis is common, leading to a high rate of lymph node metastasis (17%-45% at diagnosis), which significantly impairs quality of lif…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New hope for hard-to-treat colon cancer: combo attack with immunotherapy and radiation
Disease control Not yet recruitingThis is a randomized, parallel, open-label, multicenter exploratory clinical study designed to investigate the efficacy and safety of iparomlimab and tuvonralimab in combination with fruquintinib plus heterogeneous radiotherapy, compared with fruquintinib monotherapy, as the thir…
Phase 2 • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New drug cocktail aims to shrink esophageal tumors before surgery
Disease control Not yet recruitingIn the management of locally advanced esophageal squamous cell carcinoma, the outcomes associated with surgical resection, whether conducted alone or supplemented with postoperative adjuvant radiotherapy and chemotherapy, have been suboptimal. Immune checkpoint inhibitors (ICIs) …
Phase 2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could a simple blood injection help women with uterine scarring get pregnant?
Disease control Not yet recruitingIntrauterine adhesions (IUA) caused by endometrial basal layer injury can lead to reduced menstrual flow, infertility, recurrent pregnancy loss, and poor reproductive outcomes. Hysteroscopic adhesiolysis with uterine cavity reconstruction is the standard treatment, but women with…
Sponsor: Beijing Obstetrics and Gynecology Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New hope for hard-to-treat head and neck cancer: drug combo enters phase 2 trial
Disease control Not yet recruitingThis is a multicenter study comprising two phases: a run-in phase, including only patients receiving ficerafusp alfa and nivolumab, and a randomized phase, which corresponds to a randomized, open-label, phase II comparative study. The primary objective is to compare the objectiv…
Phase 2 • Sponsor: Groupe Oncologie Radiotherapie Tete et Cou • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Liver cancer hope: triple therapy shows promise in early trial
Disease control Not yet recruitingThis is a prospective, single-arm, phase II clinical study designed to evaluate the efficacy and safety of low-dose bevacizumab plus atezolizumab combined with transarterial chemoembolization followed by hepatic arterial infusion chemotherapy (TACE-HAIC) as first-line treatment f…
Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Magic mushroom compound tested for stubborn bipolar depression
Symptom relief Not yet recruitingThis study is a 12-week (in addition to up to 30 days of screening) randomized, double-blind, placebo-controlled, parallel-group trial. The primary objective of this study is to assess the effectiveness, safety, and tolerability of single-dose psilocybin (25 mg)-assisted therapy …
Phase 3 • Sponsor: Lakshmi N Yatham • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Arm cuff therapy may shield heart and brain after stroke
Disease control Not yet recruitingIntroduction: The management of acute myocardial injury following acute ischemic stroke (AMI-AIS), a frequent complication that severely worsens prognosis, is challenging. Remote ischemic conditioning (RIC) has demonstrated therapeutic potential in separate cardiac and cerebrovas…
Phase 3 • Sponsor: Capital Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Can a cancer drug wake up immune cells to beat HIV-Related infections?
Disease control Not yet recruitingThis prospective, single-arm, open-label study aims to evaluate the efficacy and safety of a PD-1 inhibitor (Sintilimab) combined with standard anti-infective therapy in patients with advanced HIV disease (AHD) who are suffering from refractory opportunistic infections (OIs). De…
Phase 1/2 • Sponsor: Shanghai Public Health Clinical Center • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New cell therapy targets hard-to-treat cancers with KRAS mutation
Disease control Not yet recruitingThis is a Phase 1/2, open-label, single-arm, multicenter study to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of DCTY1102 Injection in participants with advanced malignant tumors harboring KRAS/NRAS G12D mutations and positive for HLA-A11:01. DCT…
Phase 1 • Sponsor: Beijing DCTY Biotech Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Engineered immune cells take on hard-to-treat lymphoma in early trial
Disease control Recruiting nowTo evaluate the safety and tolerability of GB5005 in patients with CD19-positive relapsed/refractory B-cell non-Hodgkin lymphoma (B-NHL).
Phase 1 • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New adaptive radiation boosts rectal cancer response rates
Disease control Not yet recruitingThe aim of this clinical study is to increase the rate of pathological responses up to 70% by means of improved patient selection operated by a radiobiological index called ERI\_TCP and by an increase in the dose of radiotherapy in the final concomitant boost of preoperative radi…
Sponsor: IRCCS San Raffaele • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC